Hakimi, Abraham

Publications

Sort by

Co-Author Network

selected publications

Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy. European urology. 2022 Academic Article GET IT
Times cited: 5
Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma - An exploratory analysis. Urologic oncology. 2021 Academic Article GET IT
Times cited: 2
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy. Cancer cell. 2021 Academic Article GET IT
Times cited: 99
Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohort. Urologic oncology. 2020 Academic Article GET IT
Times cited: 3
Introduction to high throughput platforms in kidney cancer: Genomics, transcriptomics, and metabolomics urologic oncology: Seminars and original investigations. Urologic oncology. 2020 Editorial Article GET IT
Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers. Scientific reports. 2020 Academic Article GET IT
Times cited: 16
Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study. The Lancet. Oncology. 2019 Academic Article GET IT
Times cited: 95
Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical Course. European urology focus. 2019 Academic Article GET IT
Times cited: 14
The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy. European urology oncology. 2019 Academic Article GET IT
Times cited: 14
The predictive role of preoperative and postoperative neutrophil-lymphocyte ratio in sarcomatoid renal cell carcinoma. Urologic oncology. 2019 Academic Article GET IT
Times cited: 8
Clinicopathologic features associated with survival after cytoreductive nephrectomy for nonclear cell renal cell carcinoma. Urologic oncology. 2019 Academic Article GET IT
Times cited: 7
Nonenhancing Component of Clear Cell Renal Cell Carcinoma on Computed Tomography Correlates With Tumor Necrosis and Stage and Serves as a Size-Independent Prognostic Biomarker. Journal of computer assisted tomography. 2019 Academic Article GET IT
Times cited: 5
Role of lymph node dissection in renal cell cancer. Urologic oncology. 2018 Review GET IT
Times cited: 13
Cystic Renal Cell Carcinoma: A Report on Outcomes of Surgery and Active Surveillance in Patients Retrospectively Identified on Pretreatment Imaging. The Journal of urology. 2018 Academic Article GET IT
Times cited: 27
The Effect of Patient and Surgical Characteristics on Renal Function After Partial Nephrectomy. Clinical genitourinary cancer. 2017 Academic Article GET IT
Times cited: 6
Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma. European urology focus. 2017 Academic Article GET IT
Times cited: 29
Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy. Urologic oncology. 2017 Academic Article GET IT
Times cited: 19
The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma. Cell reports. 2017 Academic Article GET IT
Times cited: 125
Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome biology. 2017 Academic Article GET IT
Times cited: 7
Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer. The Journal of biological chemistry. 2016 Academic Article GET IT
Times cited: 37
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome biology. 2016 Academic Article GET IT
Times cited: 519
Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma. European urology. 2016 Academic Article GET IT
Times cited: 151
Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets. Nature communications. 2016 Academic Article GET IT
Times cited: 120
Molecular profiling of renal cell carcinoma: building a bridge toward clinical impact. Current opinion in urology. 2016 Review GET IT
Times cited: 18
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples. European urology focus. 2016 Academic Article GET IT
Times cited: 27
The difficulty in selecting patients for cytoreductive nephrectomy: An evaluation of previously described predictive models. Urologic oncology. 2016 Academic Article GET IT
Times cited: 15
Editorial Comment. The Journal of urology. 2016 Comment GET IT
Tumor Mutational Load and Immune Parameters across Metastatic Renal Cell Carcinoma Risk Groups. Cancer immunology research. 2016 Academic Article GET IT
Times cited: 55
Surgical Treatment of Tumors Involving Kidneys With Fusion Anomalies: A Contemporary Series. Urology. 2016 Academic Article GET IT
Times cited: 18
Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma. Journal of the National Comprehensive Cancer Network : JNCCN. 2016 Academic Article GET IT
Times cited: 28
Obstructive sleep apnea and Fuhrman grade in patients with clear cell renal cell carcinoma treated surgically. World journal of urology. 2016 Academic Article GET IT
Times cited: 11
Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma. Cell reports. 2016 Academic Article GET IT
Times cited: 252
Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma. British journal of cancer. 2016 Academic Article GET IT
Times cited: 38
Mitochondrial DNA copy number variation across human cancers. eLife. 2016 Academic Article GET IT
Times cited: 298
The effect of delaying nephrectomy on oncologic outcomes in patients with renal tumors greater than 4cm. Urologic oncology. 2016 Academic Article GET IT
Times cited: 27
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma. Cancer cell. 2016 Academic Article GET IT
Times cited: 417
The Genomic Landscape of Renal Oncocytoma Identifies a Metabolic Barrier to Tumorigenesis. Cell reports. 2015 Academic Article GET IT
Times cited: 101
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The New England journal of medicine. 2015 Academic Article GET IT
Times cited: 853
Prognostic Biomarkers for Response to Vascular Endothelial Growth Factor-Targeted Therapy for Renal Cell Carcinoma. The Urologic clinics of North America. 2015 Review GET IT
Times cited: 9
Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma. Cancer. 2015 Academic Article GET IT
Times cited: 15
Genomic Characterization of Upper Tract Urothelial Carcinoma. European urology. 2015 Academic Article GET IT
Times cited: 165
Respiratory gas exchange during robotic-assisted laparoscopic radical prostatectomy. Journal of clinical anesthesia. 2015 Academic Article GET IT
Times cited: 14
Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis. Cancer research. 2015 Academic Article GET IT
Times cited: 197
Partial and Radical Nephrectomy for Unilateral Synchronous Multifocal Renal Cortical Tumors. Urology. 2015 Academic Article GET IT
Times cited: 16
Metastatic non-clear cell renal cell carcinoma: an evidence based review of current treatment strategies. Frontiers in oncology. 2015 Review GET IT
Times cited: 49
TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2015 Academic Article GET IT
Times cited: 103
Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell Carcinoma. The Journal of urology. 2015 Academic Article GET IT
Times cited: 32
Cost comparison of open and robotic partial nephrectomy using a short postoperative pathway. Urology. 2015 Academic Article GET IT
Times cited: 22
Expression of Ror2 mediates invasive phenotypes in renal cell carcinoma. PloS one. 2014 Academic Article GET IT
Times cited: 19
Genomic investigation of etiologic heterogeneity: methodologic challenges. BMC medical research methodology. 2014 Academic Article GET IT
Times cited: 12
Subcentimeter pulmonary nodules are not associated with disease progression in patients with renal cell carcinoma. The Journal of urology. 2014 Academic Article GET IT
Times cited: 14
Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2014 Academic Article GET IT
Times cited: 14
The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer cell. 2014 Academic Article GET IT
Times cited: 540
The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling. Cancer medicine. 2014 Academic Article GET IT
Times cited: 94
Outcomes in patients undergoing nephrectomy for renal cancer on chronic anticoagulation therapy. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2014 Academic Article GET IT
Times cited: 8
Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Academic Article GET IT
Times cited: 173
ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. European urology. 2014 Academic Article GET IT
Times cited: 196
Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy. BJU international. 2014 Academic Article GET IT
Times cited: 28
Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma. The Journal of urology. 2014 Academic Article GET IT
Times cited: 13
Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies. Annals of oncology : official journal of the European Society for Medical Oncology. 2014 Academic Article GET IT
Times cited: 66
SQSTM1 is a pathogenic target of 5q copy number gains in kidney cancer. Cancer cell. 2013 Academic Article GET IT
Times cited: 114
An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. Journal of the National Cancer Institute. 2013 Academic Article GET IT
Times cited: 191
The association between statin medication and progression after surgery for localized renal cell carcinoma. The Journal of urology. 2013 Academic Article GET IT
Times cited: 37
Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations. Radiology. 2013 Academic Article GET IT
Times cited: 204
Comprehensive assessment of the impact of cigarette smoking on survival of clear cell kidney cancer. The Journal of urology. 2013 Academic Article GET IT
Times cited: 22
Effect of visceral obesity on minimally invasive partial nephrectomy. Urology. 2013 Academic Article GET IT
Times cited: 25
The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin. The Journal of urology. 2013 Academic Article GET IT
Times cited: 125
A clear picture of renal cell carcinoma. Nature genetics. 2013 Comment GET IT
Times cited: 88
Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Academic Article GET IT
Times cited: 1721
Factors that affect proportional glomerular filtration rate after minimally invasive partial nephrectomy. Journal of endourology. 2013 Academic Article GET IT
Times cited: 8
Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network. Clinical cancer research : an official journal of the American Association for Cancer Research. 2013 Academic Article GET IT
Times cited: 260
Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma. European urology. 2012 Academic Article GET IT
Times cited: 173
Prostate cancer: temporal predictors of functional outcome after prostatectomy. Nature reviews. Urology. 2012 Article GET IT
Minimally invasive heminephrectomy: feasibility and outcomes. Journal of endourology. 2012 Academic Article GET IT
Times cited: 1
Detection of prostate cancer in an ethnically diverse, disadvantaged population with multiple prostate specific antigen measurements before biopsy. The Journal of urology. 2012 Academic Article GET IT
Assessment of complication and functional outcome reporting in the minimally invasive prostatectomy literature from 2006 to the present. BJU international. 2011 Review GET IT
Times cited: 16
Feasibility of minimally invasive lymphadenectomy in bladder and prostate cancer surgery. The Urologic clinics of North America. 2011 Review GET IT
Times cited: 2
Preoperative and intraoperative measurements of urethral length as predictors of continence after robot-assisted radical prostatectomy. Journal of endourology. 2011 Academic Article GET IT
Times cited: 50
High-risk prostate cancer: the role of radical prostatectomy for local therapy. Future oncology (London, England). 2011 Review GET IT
Times cited: 4
Editorial comment. Urology. 2011 Editorial Article GET IT
Times cited: 1
Prostate cancer: Postprostatectomy inguinal hernia: does surgical method matter?. Nature reviews. Urology. 2010 Article GET IT
Times cited: 3
The role of preoperative endo-rectal coil magnetic resonance imaging in predicting surgical difficulty for robotic prostatectomy. Urology. 2010 Academic Article GET IT
Times cited: 30
Successful percutaneous transperineal drainage of a large prostatic abscess. 2010 GET IT
Times cited: 9
Retroperitoneal Castleman's disease. 2010 GET IT
Times cited: 3
Renal insufficiency is an independent risk factor for complications after partial nephrectomy. The Journal of urology. 2010 Academic Article GET IT
Times cited: 10
Lymph node dissection for bladder cancer: the issue of extent and feasibility in the minimally invasive era. Expert review of anticancer therapy. 2009 Review GET IT
Times cited: 4
Direct comparison of surgical and functional outcomes of robotic-assisted versus pure laparoscopic radical prostatectomy: single-surgeon experience. Urology. 2008 Academic Article GET IT
Times cited: 106
Renal medullary carcinoma: the Bronx experience. Urology. 2007 Review GET IT
Times cited: 66
From proficiency to expert, when does the learning curve for robotic-assisted prostatectomies plateau? The Columbia University experience. World journal of urology. 2007 Academic Article GET IT
Times cited: 50
Minimally invasive approaches to prostate cancer: a review of the current literature. Urology journal. 2007 Review GET IT
Times cited: 58
Prognostic nomogram for renal insufficiency after radical or partial nephrectomy. The Journal of urology. 2006 Academic Article GET IT
Times cited: 83
Complications of radical and partial nephrectomy in a large contemporary cohort. The Journal of urology. 2004 Academic Article GET IT
Times cited: 230

more ...

less ...

Background

education and training

M.D., Albert Einstein College of Medicine of Yeshiva University 2005
B.A., Cornell University 2000

Contact

full name

Abraham Hakimi

VIVO Weill Cornell Medical College

Abraham Hakimi Assistant Professor of Urology

Publications

selected publications

Background

education and training

Contact

full name